Determinants of persistent spread of HIV in HCV-infected populations of injecting drug users

Epidemics

Volumn 4, Issue 2, 2012, Pages 57-67

  De Vos, Anneke S ^a   Van der Helm, Jannie J ^b   Prins, Maria ^b,c   Kretzschmar, Mirjam E ^a,d  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b DEPARTMENT OF INFECTIOUS DISEASES   (Netherlands)

^c UNIVERSITY OF AMSTERDAM   (Netherlands)

^d NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

Author keywords

Hepatitis C Virus; HIV; Injecting drug user; Mathematical model; Risk heterogeneity

Indexed keywords

ARTICLE; CONTROLLED STUDY; GENETIC HETEROGENEITY; HEPATITIS C; HEPATITIS C VIRUS; HIGH RISK BEHAVIOR; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; INTRAVENOUS DRUG ABUSE; MATHEMATICAL MODEL; MIXED INFECTION; MORTALITY; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; VIRUS TRANSMISSION;

CAUSALITY; COHORT STUDIES; COINFECTION; COMORBIDITY; DRUG USERS; HEPATITIS C; HIV INFECTIONS; HUMANS; MODELS, STATISTICAL; NEEDLE SHARING; NETHERLANDS; PREVALENCE; PROSPECTIVE STUDIES; RISK FACTORS; RISK-TAKING; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 84857129558     PISSN: 17554365     EISSN: 18780067     Source Type: Journal    
DOI: 10.1016/j.epidem.2012.01.001     Document Type: Article

References (25)

1. Aitken C.K., Higgs P., Bowden S. Differences in the social networks of ethnic Vietnamese and non-Vietnamese injecting drug users and their implications for blood-borne virus transmission. Epidemiol. Infect. 2008, 136:410-416.
2. Andreasen V. The final size of an epidemic and its relation to the basic reproduction number. Bull. Math. Biol. 2011, 73:2305-2321.
3. Attia S., Egger M., Müller M., Zwahlen M., Low N. Sexual transmission of HIV according to viral load and antiretroviral therapy: systematic review and meta-analysis. AIDS 2009, 23:1397-1404.
4. Baggaley R.F., Boily M.C., White R.G., Alary M. Risk of HIV-1 transmission for parenteral exposure and blood transfusion: a systematic review and meta-analysis. AIDS 2006, 20:805-812.
5. Cohen M.S. Amplified transmission of HIV-1: missing link in the HIV pandemic. Trans. Am. Clin. Climatol. Assoc. 2006, 117:213-224.
6. De Carli G., Puro V., Ippolito G. Studio Italiano Rischio Occupazionale da HIV Group, Risk of hepatitis C virus transmission following percutaneous exposure in healthcare workers. Infection 2003, 31:22-27.
7. De P., Cox J., Boivin J., Platt R.W., Jolly A.M. The importance of social networks in their association to drug equipment sharing among injection drug users: a review. Addiction 2007, 1730-1739.
8. Del Fava E., Kasim A.S., Usman M., Shkedy Z., Hens N., Aerts M., Bollaerts K., Scalia Tomba G., Vickerman P., Sutton A.J., Wiessing L., Kretzschmar M. Joint modeling of HCV and HIV in Italy using repeated cross-sectional prevalence data. Stat. Commun. Infect. Dis. 2011, 3. 10.2202/1948-4690.1010.
9. Diekmann O., Heesterbeek J.A., Roberts M.G. The construction of next-generation matrices for compartmental epidemic models. J. R. Soc. Interface 2010, 7:873-885.
10. Hollingsworth T.D., Anderson R.M., Fraser C. HIV-1 Transmission, by Stage of Infection. J. Infect. Dis. 2008, 198:687-693.
11. Latkin C., Yang C., Srikrishnan A.K., Solomon S., Mehta S.H., Celentano D.D., Kumar M.S., Knowlton A., Solomon S.S. The relationship between social network factors, HIV, and Hepatitis C among injection drug users in Chennai. India. Drug. Alcohol. Depend. 2011, 117:50-54.
12. Lewis-Ximenez L.L., Lauer G.M., Schulze Zur Wiesch J., de Sousa P.S., Ginuino C.F., Paranhos-Baccal G., Ulmer H., Pfeiffer K.P., Goebel G., Pereira J.L., Mendes de Oliveira J., Yoshida C.F., Lampe E., Velloso C.E., Alves Pinto M., Coelho H.S., Almeida A.J., Fernandes C.A., Kim A.Y., Strasak A.M. Prospective follow-up of patients with acute hepatitis C virus infection in Brazil. Clin. Infect. Dis. 2010, 50:1222-1230.
13. MacDonald M., Crofts N., Kaldor J. Transmission of hepatitis C virus: rates, routes, and cofactors. Epidemiol. Rev. 1996, 18:137-148.
14. Matser A., Urbanus A., Geskus R., Kretzschmar M., Xiridou M., Buster M., Coutinho R., Prins M. The effect of hepatitis C treatment and HIV coinfection on the disease burden of hepatitis C among injecting drug users in Amsterdam. Addiction 2005, 10.1111/j.1360-0443.2011.03654.x.
15. Micallef J.M., Kaldor J.M., Dore G.J. Spontaneous viral clearance following acute hepatitis C infection: a systematic review of longitudinal studies. J. Vir. Hep 2006, 13:34-41.
16. Miller M., Mella I., Moi H., Eskild A. HIV and hepatitis C virus risk in new and longer-term injecting drug users in Oslo, Norway. J. Acquir. Immune. Def. Syndr. 2003, 33:373-379.
17. Pilcher C.D., Joaki G., Hoffman I.F., Martinson F.E., Mapanje C., Stewart P.W., Powers K.A., Galvin S., Chilongozi D., Gama S., Price M.A., Fiscus S.A., Cohen M.S. Amplified transmission of HIV-1: comparison of HIV-1 concentrations in semen and blood during acute and chronic infection. AIDS 2007, 21:1723-1730.
18. Smit C., Geskus R., Walker S., Sabin C., Coutinho R., Porter K., Prins M. CASCADE Collaboration Effective therapy has altered the spectrum of cause-specific mortality following HIV seroconversion. AIDS 2006, 20:741-749.
19. van den Berg C.H. Female Sex is the Strongest Predictor of Spontaneous Viral Clearance in a Cohort of Hepatitis C Virus Seroconverters, Amsterdam 2009, pp. 71-97, Chap. 3.1.
20. van den Berg C.H., van de Laar T.J., Kok A., Zuure F.R., Coutinho R.A., Prins M. Never injected but hepatitis C virus-infected: a study among self-declared never-injecting drug users from the Amsterdam Cohort Studies. J. Viral Hepatitis 2009, 16:568-577.
21. van den Hoek J.A., Coutinho R.A.R.A., van Haastrecht H.J., van Zadelhoff A.W., Goudsmit J. Prevalence and risk factors of HIV infections among drug users and drug-using prostitutes in Amsterdam. AIDS 1988, 2:55-60.
22. Vickerman P., Hickman M., Judd A. Modelling the impact on Hepatitis C transmission of reducing syringe sharing: London case study. Int. J. Epidemiol. 2007, 36:396-405.
23. Vickerman P.P., Platt L.L., Hawkes S. Modelling the transmission of HIV and HCV among injecting drug users in Rawalpindi, a low HCV prevalence setting in Pakistan. Sex. Transm. Infect. 2009, 85:ii23-ii30.
24. Vickerman P., Hickman M., May M., Kretzschmar M., Wiessing L. Can hepatitis C virus prevalence be used as a measure of injection-related human immunodeficiency virus risk in populations of injecting drug users? An ecological analysis. Addiction 2010, 105:311-318.
25. Yazdanpanah Y.Y., De Carli G., Migueres B., Lot F., Campins M., Colombo C., Thomas T., Deuffic-Burban S., Prevot M.H., Domart M., Tarantola A., Abiteboul D., Deny P., Pol S., Desenclos J.C., Puro V., Bouvet E. Risk factors for hepatitis C virus transmission to Health Care Workers after occupational exposure: a European case-control study. Rev. Epidemiol. Sante Publique 2006, 54. 1S23-1S31.